Platelet-derived TGF-β and direct contact between platelets and tumor cells synergistically activate TGF-β/Smad and NF-κB pathways, leading to epithelial-mesenchymal transition (EMT), increased invasion, and metastasis [58]. This evidence concerns the gene TGFB1 and neoplasm.